{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:29:01Z","timestamp":1747063741839},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,6,15]],"date-time":"2014-06-15T00:00:00Z","timestamp":1402790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s11940-014-0303-8","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T08:15:22Z","timestamp":1403165722000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Treatment Options for Thyroid Eye Disease"],"prefix":"10.1007","volume":"16","author":[{"given":"Angelique J.","family":"Pillar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Chimene","family":"Richa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,15]]},"reference":[{"key":"303_CR1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS. Graves\u2019 ophthalmopathy. N Engl J Med. 2010;362:726\u201338.","journal-title":"N Engl J Med"},{"key":"303_CR2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/105072502761016476","volume":"12","author":"WM Wiersinga","year":"2002","unstructured":"Wiersinga WM, Bartalena L. Epidemiology and prevention of Graves\u2019 ophthalmopathy. Thyroid. 2002;12:855\u201360.","journal-title":"Thyroid"},{"key":"303_CR3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.eye.6702603","volume":"21","author":"J Thornton","year":"2007","unstructured":"Thornton J, Kelly SP, Harrison RA, Edwards R. Cigarette smoking and thyroid eye disease: a systematic review. Eye. 2007;21:1135\u201345.","journal-title":"Eye"},{"issue":"1","key":"303_CR4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11940-009-0054-0","volume":"12","author":"ME Phillips","year":"2010","unstructured":"Phillips ME, Marzban MM, Kathuria SS. Treatment of thyroid eye disease. Curr Treat Options Neurol. 2010;12(1):64\u20139.","journal-title":"Curr Treat Options Neurol"},{"key":"303_CR5","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","volume":"364","author":"C Marcocci","year":"2011","unstructured":"Marcocci C, Kahaly GJ, Krassas GE, et al. Selenium and the course of mild Graves\u2019 orbitopathy. N Engl J Med. 2011;364:1920\u201331. This is an important study that demonstrates the benefit of selenium supplementation on mild thyroid eye disease.","journal-title":"N Engl J Med"},{"key":"303_CR6","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1210\/jc.2005-0148","volume":"90","author":"GJ Kahaly","year":"2005","unstructured":"Kahaly GJ, Pitz S, Hommel G, et al. Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves\u2019 orbitopathy. J Clin Endocrinol Metab. 2005;90:5234\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"303_CR7","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/bjo.2004.046193","volume":"88","author":"R Ebner","year":"2004","unstructured":"Ebner R. Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone. Br J Ophthalmol. 2004;88(11):1380\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"303_CR8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00417-012-2153-y","volume":"251","author":"SJ Lee","year":"2013","unstructured":"Lee SJ, Rim TH, Jang SY, Kim CY, Shin DY, Lee EJ, et al. Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections. Graefes Arch Clin Exp Ophthalmol. 2013;251(1):261\u201370.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"303_CR9","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0161-6420(01)00632-7","volume":"108","author":"CA Gorman","year":"2001","unstructured":"Gorman CA, Garrity JA, Fatourechi V, et al. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves\u2019 ophthalmopathy. Ophthalmology. 2001;108:1523\u201334.","journal-title":"Ophthalmology"},{"key":"303_CR10","doi-asserted-by":"crossref","unstructured":"Shams PN, Ma R, Pickles T, Rootman J, Dolman PJ. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease. Am J Ophthalmol. 2014;157(6):1299\u2013305.","DOI":"10.1016\/j.ajo.2014.02.044"},{"issue":"11","key":"303_CR11","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1210\/jc.2013-1804","volume":"98","author":"M Salvi","year":"2013","unstructured":"Salvi M, Vannucchi G, Beck-Peccoz P. Potential utility of rituximab for Graves' orbitopathy. J Clin Endocrinol Metab. 2013;98(11):4291\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"303_CR12","first-page":"173","volume":"38","author":"G Savino","year":"2013","unstructured":"Savino G, Balia L, Colucci D, Battendieri R, Gari M, Corsello SM, et al. Intraorbital injection of rituximab: a new approach for active thyroid-associated orbitopathy, a prospective case series. Minerva Endocrinol. 2013;38(2):173\u20139.","journal-title":"Minerva Endocrinol"},{"issue":"2","key":"303_CR13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/IOP.0000000000000037","volume":"30","author":"JV P\u00e9rez-Moreiras","year":"2014","unstructured":"P\u00e9rez-Moreiras JV, Alvarez-L\u00f3pez A, G\u00f3mez EC. Treatment of active corticosteroid-resistant graves' orbitopathy. Ophthal Plast Reconstr Surg. 2014;30(2):162\u20137.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"303_CR14","doi-asserted-by":"crossref","first-page":"128903","DOI":"10.1155\/2014\/128903","volume":"2014","author":"D Strianese","year":"2014","unstructured":"Strianese D, Iuliano A, Ferrara M, Comune C, Baronissi I, Napolitano P, et al. Methotrexate for the treatment of thyroid eye disease. J Ophthalmol. 2014;2014:128903.","journal-title":"J Ophthalmol"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-014-0303-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-014-0303-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-014-0303-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:57:01Z","timestamp":1559437021000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-014-0303-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,15]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["303"],"URL":"https:\/\/doi.org\/10.1007\/s11940-014-0303-8","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,15]]},"article-number":"303"}}